07 Jan2014

Astellas, ClearPath to enter strategic partnership

Posted in News, World

Astellas Pharma and ClearPath Development Company have announced a strategic partnership to build vaccine portfolio

id-100136721

Astellas received exclusive rights to acquire RSVC as well as further develop and commercialize the vaccine product

Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases.

07 Jan2014

GSK seeks FIPB nod to hike stake in India

Posted in News, World

British drugmaker GlaxoSmithKline has approached the FIPB to hike stakes in its Indian arm

id-10060620

The acquisition would result in foreign exchange inflows to the tune of Rs 6,400 crore

Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake in its domestic arm by buying 24.33 percent for an estimated Rs 6,400 crore.

Live tweets

Twitter response: "Could not authenticate you."

Contact Us

Do you have any queries?

Quick Links

About | T&C | Organization | FAQ